CHONDRONEST
ChondroNest is developing the application of this intellectual property for the reconstruction of Hyaline cartilage. They are aiming to conduct preclinical tests on animal models for two indications, the Osteochondritis and subsequently the Osteoarthrosis. After the first in-man preclinical trials the product will be licensed to major MedTech companies for sales and marketing while they will retain the production of ChondroNestโข pastes.
CHONDRONEST
Industry:
Biotechnology Health Care Medical Real Estate
Founded:
2015-01-01
Address:
Conthey, Valais, Switzerland
Country:
Switzerland
Website Url:
http://www.chondronest.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content IPv6 Cloudflare JS
Similar Organizations
Exponential Biotherapies
Exponential Biotherapies develops therapeutics to attenuate overreactions of the immune system.
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - CHONDRONEST
Official Site Inspections
http://www.chondronest.com
- Host name: h2web66.infomaniak.ch
- IP address: 83.166.138.12
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich